Laura Costas

Institut d'Investigació Biomédica de Bellvitge

Papers

1

Total Citations

5

H-Index

1

About

Dr. Laura Costas is a leading epidemiologist and public health researcher whose work focuses on the intersection of surgical oncology, cancer epidemiology, and women’s health, particularly in gynecologic cancers. Her major contributions include pioneering research on how surgical practices and quality indicators directly influence oncological outcomes, as demonstrated in her highly cited 2022 study from the Spanish National Registry. This landmark work, which has already garnered significant attention, rigorously assessed the impact of robot-assisted radical hysterectomy techniques on survival and recurrence rates for early-stage cervical cancer, establishing critical benchmarks for surgical quality. Dr. Costas’s research is instrumental in translating clinical practice into measurable patient outcomes, bridging the gap between operative technique and long-term prognosis. Her work has profound implications for standardizing care and improving survival in cervical cancer patients, making her a key voice in evidence-based surgical oncology. With a growing citation impact, Dr. Costas continues to shape guidelines and audit frameworks that empower clinicians to optimize treatment strategies for women facing cancer diagnoses.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Institut d'Investigació Biomédica de Bellvitge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago